STVN Insider Elisabetta Magistretti Buys 4,975 Shares
Elisabetta Magistretti acquired 4,975 shares of Stevanato Group S.p.A. on June 12, 2026, joining a busy week of executive transactions.
Reviewed by automated data checks against the source filing. How we make and check alerts
Elisabetta Magistretti bought 4,975 shares of Stevanato Group S.p.A. ($STVN) on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $STVN is down 0.8% after 1 week, up 15.8% after 1 month and up 10.7% to date (from the $17.08 close on Jun 12, 2026).
Key Points
- Elisabetta Magistretti bought 4,975 shares of Stevanato Group S.p.A. STVN on June 12, 2026.
- The stock traded around $18.39 per share on Friday, sitting well below its 52-week high of $27.99.
- Several other company leaders, including Sue-Jean Lin and Karen Flynn, also picked up 4,975 shares each on the same date.
Get $STVN trade alerts by text
We text you when insiders, Congress or big funds trade $STVN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Stevanato Group S.p.A. alert may contain errors. Disclosures
Elisabetta Magistretti Grows Stake in Stevanato Group S.p.A.
Elisabetta Magistretti bought 4,975 shares of Stevanato Group S.p.A. (NYSE: STVN) on June 12, 2026. This purchase adds to a flurry of recent insider moves at the medical technology firm, following previous reports of executive buying and selling earlier in the month.
Stevanato Group Stock Trades Below Recent Highs
The medical device maker's shares traded hands at $18.39 on Friday. The stock has experienced a wide trading range over the past year, hitting a low of $12.89 and a high of $27.99. Its 50-day moving average sits at $20.98, while the 200-day moving average stands closer to $18.19.
Recent Insider Transactions at Stevanato Group
The June 12 transaction took place alongside similar purchases by other insiders. Sue-Jean Lin and Karen Flynn each acquired 4,975 shares on June 12, 2026. Madhavan Balachandran also bought 4,975 shares on the same day. Meanwhile, Chief Financial Officer Dal Lago Marco parted with 7,997 shares on June 12, and Chief Business Strategy Officer Mauro Stocchi completed transactions involving 6,586 shares on June 9.
Inside Stevanato Group S.p.A. Operations
Stevanato Group S.p.A. designs and manufactures specialized glass packaging, drug delivery systems, and diagnostic components for the pharmaceutical and biotechnology industries. Headquartered in Italy and founded in 1949, the firm provides vital components like pre-fillable syringes and auto-injectors to healthcare companies across the globe.
What to Watch Next for STVN
Investors will keep an eye on upcoming regulatory filings and the company's next earnings report, scheduled for November 5, 2026, to gauge how operational growth measures up against recent executive share activity.
Source: Elisabetta Magistretti's Form 4 filing on $STVN (Jun 12, 2026). Find the original filing: STVN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
